Dr. Rena Callahan, a hematologist-oncologist of the Ronald Reagan UCLA Medical Center and Assistant Clinical Professor of Medicine at the David Geffen School of Medicine at UCLA, discusses HER2+ breast cancer, its current treatment, and possible treatment advances. This webinar took place on December 3, 2018.